netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

Chapter Links...
 Details...
03.04.02  Expand sub section  Allergen Immunotherapy
 note  Refer to BNF for advice, safety information and cautions for allergen immunotherapy.  RESTRICTED USE - SPECIALIST USE ONLY
03.04.02  Expand sub section  Omalizumab, mepolizumab and other therapies
 note 
Benralizumab injection
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
NHS England
BlueTeq

For use in asthma within the specialist service as per NICE TA 

 
Link  NICE TA565: Benralizumab for treating severe eosinophilic asthma
   
Mepolizumab injection
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
BlueTeq

For use in asthma within the specialist service as per NICE TA 

 
Link  NICE TA431: Mepolizumab for treating severe refractory eosinophilic asthma
   
Omalizumab injection (asthma)
View adult BNF View SPC online
Restricted Drug Restricted
Red
High Cost Medicine
BlueTeq

For use in asthma within the specialist service as per NICE TA 

 
Link  NICE TA278: Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201)
   
Omalizumab injection (urticaria)
View adult BNF View SPC online
Restricted Drug Restricted
Red
High Cost Medicine

For use in chronic spontaneous urticaria (as per NICE TA below), and chronic inducible urticarias (approved off-label use).

NOTE: see formulary section 3.4.4 (management of urticaria), and the SEL APC Urticaria Treatment Pathway for more detailed advice on the management of urticaria (link below)

For use in inducible urticaria (i.e. off-label use), a category B* form must be completed. 

 
Link  NICE TA339: Omalizumab for previously treated chronic spontaneous urticaria
Link  SE London APC recommendation: Omalizumab for the treatment of inducible urticarias (symptomatic dermographism, cholinergic, delayed pressure, cold and solar) in adults
   
Reslizumab injection
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
NHS England
BlueTeq

For use in asthma within the specialist service as per NICE TA

 
Link  NICE TA479: Reslizumab for treating severe eosinophilic asthma
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary